Cargando…

IDF21-0444 Association Between Prior Antidiabetic Therapy and Outcome in Hospitalized COVID-19 Diabetic Subjects

Detalles Bibliográficos
Autores principales:	Baidya, A., Ahmed, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164773/ http://dx.doi.org/10.1016/j.diabres.2022.109358

Ejemplares similares

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

IDF21-0123 Impact of Pre-existing Oral Antidiabetic Treatment on Clinical Outcomes of COVID-19: a Retrospective Study
por: Navale, A., et al.
Publicado: (2022)

P.0444 The use of prescription analgesics during COVID-19 lockdown in the Netherlands
por: Saeed, H., et al.
Publicado: (2021)

P04.44. The association between the use of complementary and alternative medicine in children with demographic indicators and vaccinations
por: Feiler-Mircus, N
Publicado: (2012)

IDF21-0275 Association between hyperglycemia treatment and mortality in patients with diabetes and COVID-19 in a Peruvian hospital
por: Lopez-Huamanrayme, E., et al.
Publicado: (2022)

IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes
por: Iommi, M., et al.
Publicado: (2022)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

IDF21-0663 Health-Related Quality of Life in Moroccan patients with diabetes after hospitalization for COVID-19
por: Azizi, A., et al.
Publicado: (2022)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0190 Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes
por: Munda, A., et al.
Publicado: (2022)

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection
por: Bogdanovic, J., et al.
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection
por: Babic, I., et al.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0390 Diabetes related hospital presentations to South-Western Sydney during COVID Pandemic: A retrospective analysis
por: Namboodiri, D., et al.
Publicado: (2022)

IDF21-0452 Virtual Diabetes Education Program for Children and Adolescents with Diabetes in Response to COVID-19 Pandemic
por: Alromaihi, D., et al.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0110 The role of source hypoglycemic therapy and associated diseases in patients with type 2 diabetes mellitus and COVID-19
por: Markova, T.N., et al.
Publicado: (2022)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

IDF21-0439 Type 2 Diabetes Mellitus History in the Prognosis of Hospitalized COVID-19 Patients – A Prospective Observational Study
por: Kochuparambil, J.J., et al.
Publicado: (2022)

COVID-19 and diabetes from IDF MENA region
por: Belkhadir, Jamal
Publicado: (2020)

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories
por: Dapice, A.
Publicado: (2022)

A Multicentre, Multinational, Open-Label, 52-Week Extension Study of Gemigliptin (LC15-0444) Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Yang, Sae Jeong, et al.
Publicado: (2021)

IDF21-0470 Neither plasma glucose at admission nor in-hospital hyperglycaemia predict poor clinical outcomes in COVID-19 patients
por: Sharma, P., et al.
Publicado: (2022)

IDF21-0273 New-Onset Diabetic Ketoacidosis as a first manifestation of Covid-19 at emergency department
por: Dhokar, R., et al.
Publicado: (2022)

IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic
por: Quinto, C.J., et al.
Publicado: (2022)

IDF21-0616 Observational study on covid 19 and type 1 diabetes in the Chronic Care Center Lebanon
por: Maalouf Nawfal, P., et al.
Publicado: (2022)

IDF21-0080 Determinants of acceptability to COVID-19 vaccine among the general public and diabetes population in Israel
por: Kolobov, T., et al.
Publicado: (2022)

IDF21-0211 Relationship between COVID-19 disrupted lifestyle habits and mental health in Canadian adults with type 1 diabetes
por: Tang, T., et al.
Publicado: (2022)

IDF21-0416 Mortality risk factors due to COVID-19 in diabetic patients according to the nationwide diabetes register analysis
por: Shestakova, M., et al.
Publicado: (2022)

Diabetes and COVID-19: IDF perspective in the Western Pacific region
por: Hwang, Yerin, et al.
Publicado: (2020)

IDF21-0498 Innovative ways to continue serving People with Type 1 Diabetes during Covid 19 pandemic
por: Abi Saad, M., et al.
Publicado: (2022)

IDF21-0353 Covid19 toe, a late manifestation of mild SARS-CoV-2 with Diabetes
por: Jain, R., et al.
Publicado: (2022)

IDF21-0097 Concomitant COVID-19 Infection and Ketosis Prone Diabetes. Coincidence or Relationship? A Case Report
por: Gonzalez, L., et al.
Publicado: (2022)

IDF21-0168 Pathway to Clinical Diabetes Services in COVID-19 Era: What Has Changed and What Are the Implications?
por: Adwubi, E., et al.
Publicado: (2022)

IDF21-0302 A human digital interface uniquely supports diabetes patient care during COVID 19
por: Mehrotra, R.N., et al.
Publicado: (2022)

IDF21-0090 Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia
por: Tojieva, I., et al.
Publicado: (2022)

Shape the future of diabetes at the IDF World Diabetes Congress 2022
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pmr04fiqu2h693bt9qmjn8v1ep